Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Series A brings in $4.6mm for three-year-old Airway Therapeutics

11 Sep 2014

Executive Summary

Pulmonary disease-focused Airway Therapeutics LLC raised $4.6mm in its Series A financing led by CincyTech, which was joined by Cincinnati Children's Hospital Medical Center (from which the company licensed IP to begin operations), Queen City Angels, and private investors. Proceeds will support ongoing development of AT100, a recombinant protein in preclinical studies for bronchopulmonary dysplasia. The firm raised $500k in its June 2011 seed round.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By